Glucosamine / joint health, health claims received negative opinion from EFSA: Why?

Following the negative opinion on health claims submitted for glucosamine and joint in general, it is no longer possible to communicate on such products which are the first global marketplace for food supplement!

Indeed, studies showing the efficacy of glucosamine on joints have mainly been performed in populations of patients with osteoarthritis and arthritis. This target population can not support scientific evidence in food supplements.

As we anticipated, expressed long time ago (interview nutraingredient) and already in progress through several studies, it is necessary to justify the efficacy of glucosamine (as other ingredients for joint) in healthy subjects.

All claims are accessible online on Nutraveris’on line

NOL Data Solution
NOL Compliance